Literature DB >> 17237620

Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

Geraldine Flynn1, Ivy Chung, Wei-Dong Yu, Michelle Romano, Ruth A Modzelewski, Candace S Johnson, Donald L Trump.   

Abstract

Calcitriol (1,25-dihydroxycholecalciferol) has antiproliferative and/or proapoptotic effects on many cell types and the glucocorticoid dexamethasone enhances these effects. We have shown that calcitriol modulates several key signaling proteins involved in differentiation, proliferation and apoptosis in tumor-derived murine endothelial cells (TDEC) and that these effects were not seen with endothelial cells isolated similarly from normal tissues. In the present study, TDEC and mouse embryonic yolk sac endothelial cells (MYSEC) were treated with calcitriol and followed over time for an effect. MYSEC were utilized as 'normal' control endothelial cells because they were more primitive, being isolated from a highly neovascular tissue, and had a similar morphology without the stimulus of the tumor microenvironment. The vitamin D receptor (VDR) is present in TDEC and MYSEC, and was upregulated in calcitriol-treated TDEC and MYSEC; dexamethasone further increased VDR expression following 48 h of treatment. The modulatory effects on signaling proteins were maximal by treatment for 48 h; phospho-Erk, phospho-Akt, p21 and bcl-2 were decreased in treated TDEC with the induction of p27 but there were no effects on MYSEC. After 48 h increased apoptosis was seen in treated TDEC by annexin V labeling with caspase-3 cleavage and decreased levels of poly(ADP-ribose) polymerase, but no effects were seen in MYSEC. Cell cycle analysis showed increased G(0)/G(1) arrest and an increase in the apoptotic sub-G(1) peak in treated TDEC but similar effects were not seen in MYSEC following 48-hour treatment. Proliferation assays were utilized and TDEC demonstrated decreased proliferation compared to normal endothelial cells at 48 h. To determine whether or not the VDR signaling was impaired in MYSEC, we performed the 24-hydroxylase (CYP24) promoter-luciferase reporter assay. CYP24 is a key enzyme involved in the breakdown of vitamin D. VDR signaling was intact in both cell types and calcitriol induced CYP24 mRNA expression in MYSEC but not in TDEC. Taken together, despite similar levels of VDR expression and intact signaling in both cell types, calcitriol selectively inhibits proliferation and induces apoptosis in TDEC with no effect on MYSEC. Thus calcitriol exerts differential effects on TDEC compared to normal cells. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237620     DOI: 10.1159/000098872

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  17 in total

1.  Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.

Authors:  Alejandro A Hidalgo; Kristin K Deeb; J Wesley Pike; Candace S Johnson; Donald L Trump
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

2.  Glucocorticoid regulation of the vitamin D receptor.

Authors:  Alejandro A Hidalgo; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-14       Impact factor: 4.292

3.  VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2011-11-22

Review 4.  Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

Authors:  Alejandro S Godoy; Ivy Chung; Viviana P Montecinos; Ralph Buttyan; Candace S Johnson; Gary J Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

5.  Epigenetic silencing of CYP24 in the tumor microenvironment.

Authors:  Candace S Johnson; Ivy Chung; Donald L Trump
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

6.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

7.  25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.

Authors:  Xinjian Peng; Michael Hawthorne; Avani Vaishnav; René St-Arnaud; Rajendra G Mehta
Journal:  Breast Cancer Res Treat       Date:  2008-01-20       Impact factor: 4.872

Review 8.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

9.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

10.  Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.

Authors:  Thilo S Lange; Ashley R Stuckey; Katina Robison; Kyu Kwang Kim; Rakesh K Singh; Christina A Raker; Laurent Brard
Journal:  Invest New Drugs       Date:  2009-07-07       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.